An Atherogenic Paigen-Diet Aggravates Nephropathy in Type 2 Diabetic OLETF Rats

Masanori Nozako; Takashi Koyama; Chifumi Nagano; Makoto Sato; Satoshi Matsumoto; Kiminobu Mitani; Reiko Yasufuku; Masayuki Kohashi; Tomohiro Yoshikawa

doi:10.1371/journal.pone.0143979

Loading metrics

Open Access

Peer-reviewed

Research Article

An Atherogenic Paigen-Diet Aggravates Nephropathy in Type 2 Diabetic OLETF Rats

Masanori Nozako,

Affiliations Free Radical Research Project, Otsuka Pharmaceutical Co., Ltd., Tokushima, Tokushima, Japan, Department of Toxicology, Drug Safety Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Tokushima, Japan
⨯
Takashi Koyama,

Affiliations Free Radical Research Project, Otsuka Pharmaceutical Co., Ltd., Tokushima, Tokushima, Japan, Department of Toxicology, Drug Safety Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Tokushima, Japan
⨯
Chifumi Nagano,

Affiliations Free Radical Research Project, Otsuka Pharmaceutical Co., Ltd., Tokushima, Tokushima, Japan, Department of Toxicology, Drug Safety Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Tokushima, Japan
⨯
Makoto Sato,

Affiliation Department of Toxicology, Drug Safety Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Tokushima, Japan
⨯
Satoshi Matsumoto,

Affiliation Department of Toxicology, Drug Safety Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Tokushima, Japan
⨯
Kiminobu Mitani,

Current address: First Institute of New Drug Discovery, Otsuka Pharmaceutical Co., Ltd., Tokushima, Tokushima, Japan

Affiliation Free Radical Research Project, Otsuka Pharmaceutical Co., Ltd., Tokushima, Tokushima, Japan
⨯
Reiko Yasufuku,

Current address: First Institute of New Drug Discovery, Otsuka Pharmaceutical Co., Ltd., Tokushima, Tokushima, Japan

Affiliation Free Radical Research Project, Otsuka Pharmaceutical Co., Ltd., Tokushima, Tokushima, Japan
⨯
Masayuki Kohashi,

Current address: First Institute of New Drug Discovery, Otsuka Pharmaceutical Co., Ltd., Tokushima, Tokushima, Japan

Affiliation Free Radical Research Project, Otsuka Pharmaceutical Co., Ltd., Tokushima, Tokushima, Japan
⨯
Tomohiro Yoshikawa

* E-mail: yoshikawa.tomohiro.a@otsuka.jp

Current address: First Institute of New Drug Discovery, Otsuka Pharmaceutical Co., Ltd., Tokushima, Tokushima, Japan

Affiliation Free Radical Research Project, Otsuka Pharmaceutical Co., Ltd., Tokushima, Tokushima, Japan
⨯

An Atherogenic Paigen-Diet Aggravates Nephropathy in Type 2 Diabetic OLETF Rats

Masanori Nozako,
Takashi Koyama,
Chifumi Nagano,
Makoto Sato,
Satoshi Matsumoto,
Kiminobu Mitani,
Reiko Yasufuku,
Masayuki Kohashi,
Tomohiro Yoshikawa

Published: November 25, 2015
https://doi.org/10.1371/journal.pone.0143979

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Kidneys
Is the Subject Area "Kidneys" applicable to this article?

Thanks for your feedback.
Diet
Is the Subject Area "Diet" applicable to this article?

Thanks for your feedback.
Excretion
Is the Subject Area "Excretion" applicable to this article?

Thanks for your feedback.
Blood plasma
Is the Subject Area "Blood plasma" applicable to this article?

Thanks for your feedback.
Urine
Is the Subject Area "Urine" applicable to this article?

Thanks for your feedback.
Cholesterol
Is the Subject Area "Cholesterol" applicable to this article?

Thanks for your feedback.
Creatinine
Is the Subject Area "Creatinine" applicable to this article?

Thanks for your feedback.
Albumins
Is the Subject Area "Albumins" applicable to this article?

Thanks for your feedback.